Literature DB >> 32851368

Correlations Between Clinical Features and Mouth Opening in Patients With Systemic Sclerosis.

İpek TÜrk1, Nihan CÜzdan2, Volkan ÇİftÇİ3, Didem Arslan1, İlker Ünal4.   

Abstract

OBJECTIVES: This study aims to investigate the correlations between clinical features and mouth opening in patients with systemic sclerosis (SSc). PATIENTS AND METHODS: Eighty patients with SSc (13 males, 67 females; mean age 53.39±11.65 years; range, 31 to 76 years) followed in our clinic were enrolled in the study. Skin involvement was assessed using the modified Rodnan skin score (mRSS), joint/tendon involvement with finger-tip to palm (FTP) distance and interstitial lung disease (ILD) was evaluated with clinical and radiologic methods. The interincisal distance (ID) measurement was used to assess the maximal mouth opening capacity. We examined associations between the ID and clinical features of SSc.
RESULTS: The ID was lower in females compared with males, and in diffuse type compared with the limited type (p<0.001 and p<0.001, respectively). A significant negative correlation was found between the ID with mRSS and FTP distance (p<0.001 and p=0.001, respectively). The ID was lower in patients with ILD than in patients without ILD (p=0.006). A formula was constituted to predict the maximal mouth opening of the patient with regression analysis. According to the formula, being male was associated with an increase of 6.14 mm, the presence of ILD with a decrease of 3.19 mm, every 10 mm increment in mRSS with a decrease of 3.72 mm and FTP distance >0 mm with a decrease of 5.13 mm in mouth opening.
CONCLUSION: Microstomia is associated with low quality of life in patients with SSc. In our study, sex, ILD, mRSS, and FTP distance were observed to be the most important factors that were related with mouth opening in patients with SSc.
Copyright © 2020, Turkish League Against Rheumatism.

Entities:  

Keywords:  Interincisal distance; microstomia; mouth opening; systemic sclerosis

Year:  2020        PMID: 32851368      PMCID: PMC7406162          DOI: 10.46497/ArchRheumatol.2020.7434

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  30 in total

Review 1.  Assessment of disease severity and prognosis.

Authors:  T A Medsger; S Bombardieri; L Czirjak; R Scorza; A Della Rossa; W Bencivelli
Journal:  Clin Exp Rheumatol       Date:  2003       Impact factor: 4.473

2.  The psychological impact of facial changes in scleroderma.

Authors:  Kavit Amin; A Clarke; B Sivakumar; A Puri; Z Fox; V Brough; C P Denton; E M Peter; P Butler; M D Butler
Journal:  Psychol Health Med       Date:  2011-05       Impact factor: 2.423

3.  Clinical significance of subcutaneous calcinosis in patients with systemic sclerosis. Does diltiazem induce its regression?

Authors:  M Vayssairat; D Hidouche; N Abdoucheli-Baudot; J P Gaitz
Journal:  Ann Rheum Dis       Date:  1998-04       Impact factor: 19.103

4.  Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis.

Authors:  Kathryn S Torok; Nancy A Baker; Mary Lucas; Robyn T Domsic; Robert Boudreau; Thomas A Medsger
Journal:  Clin Exp Rheumatol       Date:  2010-06-10       Impact factor: 4.473

Review 5.  Pleuropulmonary pathology in patients with rheumatic disease.

Authors:  Frank Schneider; James Gruden; Henry D Tazelaar; Kevin O Leslie
Journal:  Arch Pathol Lab Med       Date:  2012-10       Impact factor: 5.534

6.  High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.

Authors:  P J Clements; D E Furst; W K Wong; M Mayes; B White; F Wigley; M H Weisman; W Barr; L W Moreland; T A Medsger; V Steen; R W Martin; D Collier; A Weinstein; E Lally; J Varga; S Weiner; B Andrews; M Abeles; J R Seibold
Journal:  Arthritis Rheum       Date:  1999-06

7.  Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.

Authors:  U A Walker; A Tyndall; L Czirják; C Denton; D Farge-Bancel; O Kowal-Bielecka; U Müller-Ladner; C Bocelli-Tyndall; M Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2007-01-18       Impact factor: 19.103

8.  Effects of a nonsurgical exercise program on the decreased mouth opening in patients with systemic scleroderma.

Authors:  G Pizzo; G A Scardina; P Messina
Journal:  Clin Oral Investig       Date:  2003-07-09       Impact factor: 3.573

9.  Occlusal and MRI characterizations in systemic sclerosis patients: A prospective study from Southern Italian cohort.

Authors:  Giovanni Matarese; Gaetano Isola; Angela Alibrandi; Alberto Lo Gullo; Gianluca Bagnato; Giancarlo Cordasco; Letizia Perillo
Journal:  Joint Bone Spine       Date:  2015-11-06       Impact factor: 4.929

10.  Orofacial Manifestations and Temporomandibular Disorders of Systemic Scleroderma: An Observational Study.

Authors:  Vito Crincoli; Laura Fatone; Margherita Fanelli; Rossana Patricia Rotolo; Angela Chialà; Gianfranco Favia; Giovanni Lapadula
Journal:  Int J Mol Sci       Date:  2016-07-22       Impact factor: 5.923

View more
  2 in total

1.  Oral manifestations of patients with systemic sclerosis: a meta-analysis for case-controlled studies.

Authors:  Suhan Zhang; Junfei Zhu; Yanshan Zhu; Xiaochao Zhang; Ruifang Wu; Siying Li; Yuwen Su
Journal:  BMC Oral Health       Date:  2021-05-10       Impact factor: 2.757

2.  Dental implants in patients suffering from systemic sclerosis: a retrospective analysis of clinical outcomes in a case series with 24 patients.

Authors:  Jochen Jackowski; Frank Peter Strietzel; Nicolas Hunzelmann; Parwana Parwani; Angelika Jackowski; Korbinian Benz
Journal:  Int J Implant Dent       Date:  2021-12-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.